Karboderm - Darnitsa

General characteristics. Structure:

Active ingredient: 1 g of cream contains 50 mg or 100 mg of urea (in terms of 100% dry matter);

excipients: cetylpyridinium chloride, propylene glycol, oil mineral, cetostearyl alcohol, the water purified.

Pharmacological properties:

Karboderm-Darnits's cream renders the hydrating, keratolytic, antipruritic, antibacterial and antifungal action. As a result of use of cream manifestations of a hyperkeratosis decrease, skin is softened and moistened, its elasticity increases, epithelization of superficial damages improves. Drug urea in concentration of 10% works bakteritsidno and fungitsidno thanks to a tsitilpiridiniya to chloride which is a part of drug. In concentration of 5% urea of drug works bakteriostatichno and fungistatichno. Due to weak mestnoanesteziruyushchy effect of urea drug has antipruritic effect.

High-molecular polymeric substances of an ointment basis hold urea on a surface of a site of application, prevent its transdermalny absorption, thanks to it urea does not get to a system blood stream.

Indications to use:

Treatment of the diseases of skin which are followed by the increased formation of the keratosic epithelium.

Karboderm-Darnits's cream of 5% is applied to treatment of chronic likhenifitsirovanny eczema, neurodermatitis, atopic dermatitis, psoriasis (except for exudative forms).

Karboderm-Darnits's cream of 10% is applied to treatment of psoriasis (in a stationary stage at the expressed infiltration), seborrheas, keratomycoses, giperkeratoz, giperkeratichesky forms of eczema, an ichthyosis.

Route of administration and doses:

Drug is used for treatment of adults.

The doctor appoints concentration of drug (5% or 10%), and also a cream dose individually depending on a type of a disease, extent of defeat and size of an affected area. Cream (on average 1-4 cm) is applied on an affected area of skin by 2 times a day. For increase in efficiency of treatment use of occlusive bandages is possible; cream with concentration of urea of 5% can be used when carrying out a fonoforez.

The treatment duration which can average 1-2 weeks, the doctor depending on a look and disease severity defines, considering regression of symptoms of infiltration and lichenification of skin.

Features of use:

In order to avoid impact on healthy fabrics it is desirable that the site of skin on which apply cream did not exceed the size of the struck zone.

Use during pregnancy or feeding by a breast.

Drug is used during pregnancy or feeding by a breast.

Ability to influence speed of response at control of motor transport or work with other mechanisms.

Drug does not influence speed of response at control of motor transport or work with other mechanisms.

Children.

Drug is not appointed to children due to the lack of clinical experience.

Side effects:

In isolated cases development of dermatological reactions is possible: erubescence, itch, pricking and irritation of skin.

Emergence of burning sensation which arises when imposing an occlusive bandage more often is occasionally possible.

Interaction with other medicines:

Interaction of cream of Karboderm-Darnits with other drugs is not revealed, however it is necessary to consider that simultaneous use of cream with other ointments or creams can lead to strengthening of absorption of the medicinal substances which are their part.

Contraindications:

Use of cream of Karboderm-Darnits is contraindicated at individual hypersensitivity to urea or other components of cream, and also at the dermatosis which is followed by the expressed exudation.

Overdose:

Overdose cases are not revealed by Karboderm-Darnits's drug.

Storage conditions:

Period of validity. 2 years. To store in the place, unavailable to children, in original packaging, at a temperature from 15 °C to 25 °C.

Issue conditions:

Without recipe

Packaging:

On 30 g in tubas, on 1 tuba in a pack.